FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064193 [Registered on: 15/03/2024] Trial Registered Prospectively
Last Modified On: 12/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   PROSPECTIVE OBSERVATIONAL STUDY 
Study Design  Other 
Public Title of Study   Evaluating the Health-Related Quality of Life in patients undergoing definitive management for Head and Neck Squamous Cell Carcinoma 
Scientific Title of Study   Assessment of Health-Related Quality of Life (HR-QoL) of Patients During Definitive Management of Head and Neck Squamous Cell Carcinoma  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Advait Bhuran 
Designation  Junior Resident 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Room no 405, OPD 4A, Department of Otorhinolaryngology, All India Institute of Medical Sciences, Jodhpur-342005.

Jodhpur
RAJASTHAN
342005
India 
Phone  8369558530  
Fax    
Email  bhuranadvait@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vidhu Sharma  
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Room no 411, OPD 4A, Department of Otorhinolaryngology, All India Institute of Medical Sciences, Jodhpur-342005.

Jodhpur
RAJASTHAN
342005
India 
Phone  09816165999  
Fax    
Email  vidhusharma88@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Advait Bhuran 
Designation  Junior Resident 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Room no 405, OPD 4A, Department of Otorhinolaryngology, All India Institute of Medical Sciences, Jodhpur-342005.

Jodhpur
RAJASTHAN
342005
India 
Phone  8369558530  
Fax    
Email  bhuranadvait@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences Jodhpur 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Jodhpur 
Address  All India Institute of Medical Sciences Jodhpur, Basini Phase-II, Jodhpur, Rajasthan-342005 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Advait Bhuran  All India Institute of Medical Sciences Jodhpur  Room no 405, OPD 4A, Department of Otorhinolaryngology, All India Institute of Medical Sciences, Jodhpur-342005.
Jodhpur
RAJASTHAN 
08369558530

bhuranadvait@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTINAL ETHICS COMMITTEE AIIMS JODHPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C029||Malignant neoplasm of tongue, unspecified, (2) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx, (3) ICD-10 Condition: C049||Malignant neoplasm of floor of mouth, unspecified, (4) ICD-10 Condition: C039||Malignant neoplasm of gum, unspecified, (5) ICD-10 Condition: C059||Malignant neoplasm of palate, unspecified, (6) ICD-10 Condition: C109||Malignant neoplasm of oropharynx,unspecified, (7) ICD-10 Condition: C119||Malignant neoplasm of nasopharynx,unspecified, (8) ICD-10 Condition: C12||Malignant neoplasm of pyriform sinus, (9) ICD-10 Condition: C139||Malignant neoplasm of hypopharynx,unspecified, (10) ICD-10 Condition: C099||Malignant neoplasm of tonsil, unspecified, (11) ICD-10 Condition: C069||Malignant neoplasm of mouth, unspecified, (12) ICD-10 Condition: C089||Malignant neoplasm of major salivary gland, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL   NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All patients undergoing definitive treatment (surgery followed by adjuvant radiotherapy/chemoradiation or definitive radiotherapy/ chemoradiation) for Head and Neck Squamous Cell Carcinoma at AIIMS Jodhpur 
 
ExclusionCriteria 
Details  Patients undergoing only surgery as a part of definitive treatment
Patients undergoing palliative treatment
Patients who have taken treatment at other centers
Patients with recurrent disease
Patients who do not consent to participate
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Health related Quality of life of patients during Definitive management of Head and Neck Squamous cell carcinoma at AIIMS Jodhpur  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Short term factors influencing health related quality of life  1 year 
Pattern of change in different domains of quality of life during treatment  1 year 
Factors affecting discontinuation of treatment   1 year 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Different domains of HRQoL are affected differently at various times of treatment and hence it needs further evaluation to provide the right kind of support. By synthesizing and critically analyzing the available evidence, this study seeks to identify the most affected domains of HRQoL at various time-points of treatment. Furthermore, the research aims to explore the factors influencing HRQoL in HNSCC patients and investigate the potential impact of different treatment modalities on their well-being.
The findings from this study will contribute to a deeper understanding of the HRQoL challenges faced by patients with HNSCC and inform healthcare providers in tailoring personalized care plans. Ultimately, this research endeavors to enhance the quality of life for individuals living with HNSCC and foster a patient-centered approach that encompasses not only clinical outcomes but also the holistic well-being of those affected by this devastating disease.

 
Close